The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ

FDA approves controversial Biogen Alzheimer's drug | DW NewsПодробнее

What Is Aducanumab and How Does It Work | New Biogen Alzheimer's drug 101Подробнее

Experts responds to fda approval of aducanumab | Being PatientПодробнее

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 YearsПодробнее

Controversy over newly approved Alzheimer's drugПодробнее

What Is Aduhelm and How Does It Fight Alzheimer’s?Подробнее

Dr Sam Moxon - The Aduhelm ParadoxПодробнее

The FDA Has Approved Aducanumab (Aduhelm™). Now What?Подробнее

New Hope for Alzheimer's PatientsПодробнее

FDA decision on experimental Alzheimer's drug expected this weekПодробнее

Reaction to Alzheimer's drug approvalПодробнее

FDA approves controversial Alzheimer's drugПодробнее

FDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectivenessПодробнее

The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug ApprovalsПодробнее

“Aduhelm, Is This Medication Changing the Game for Alzheimer’s Disease?” Gregory Cooper, M.D., Ph.D.Подробнее

Alzheimer's drug Aduhelm explained | Aducanumab and Alzheimer's disease #AduhelmПодробнее

FDA Approves New Drug for the Treatment of Alzheimer's Disease (Joel Shenker, MD, PhD)Подробнее

FDA pulls back on blanket approval of controversial treatment drug used on Alzheimer's patientsПодробнее

What’s The Controversy Behind Biogen’s Alzheimer’s Drug?Подробнее